• Profile
Close

Cervicovaginal fluid proteomic analysis to identify potential biomarkers for preterm birth

American Journal of Obstetrics and Gynecology May 01, 2020

Parry S, Leite R, Esplin MS, et al. - Using targeted and shotgun proteomic analyses, researchers sought to determine cervicovaginal fluid biomarkers of early spontaneous preterm birth in a high-risk cohort of pregnant women with a history of spontaneous preterm birth. In this nested case control study (cases were spontaneous preterm birth < 34 weeks in the current pregnancy; controls were spontaneous labor and delivery at 39–41 weeks), collection of cervicovaginal fluid samples was performed at 3 study visits (10 0/7 to 18 6/7 weeks, 19 0/7 to 23 6/7 weeks, and 28 0/7 to 31 6/7 weeks). A history of at least 1 prior spontaneous preterm birth was reported in all participants. Targeted and shotgun proteomics analyses revealed potential biomarkers of spontaneous preterm birth in cervicovaginal fluid samples from high-risk, asymptomatic women. Cervicovaginal fluid samples from spontaneous preterm birth cases displayed higher level of many proteins; of these, many are extracellular matrix proteins and/or regulate cell membrane physiology. Despite substantial biological interest in these proteins, validation enzyme-linked immunosorbent assay for 5 of these proteins did not provide clinically valuable biomarkers for spontaneous preterm birth.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay